A study of lenabasum for the treatment of Dermatomyositis (DM).
Phase of Trial: Phase III
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Ajulemic acid (Primary)
- Indications Dermatomyositis
- Focus Therapeutic Use
- 08 Mar 2018 New trial record
- 02 Mar 2018 According to a media release, company expects to start this study in the second half of 2018.